πŸ‡ΊπŸ‡Έ FDA
Patent

US 11124489

EPAC antagonists

granted A61KA61K31/15A61K31/42

Quick answer

US patent 11124489 (EPAC antagonists) held by The Board of Regents of the University of Texas System expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/15, A61K31/42, A61K31/423, A61K45/06